The Mosaic Company (MOS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 Aug, 2026Executive summary
Q2 2026 reported a net loss of $273 million, with diluted EPS of $(0.86) and adjusted EBITDA of $407 million, reflecting lower sales volumes, higher input costs, and significant asset impairments, including $351 million in notable items and $482 million in related charges.
Revenues were $2.82–$2.824 billion, down 6% year-over-year, with gross margin declining 59% to 8% of sales.
Phosphate and Mosaic Fertilizantes segments posted operating losses, while Potash remained profitable.
Strategic actions included the sale of the Carlsbad potash mine, divestiture of Araxá, and idling of Patrocínio mining activities in Brazil.
Cost controls, capital reallocation, and strong liquidity measures were implemented to offset market headwinds.
Financial highlights
Adjusted EBITDA for Q2 2026 was $407 million, with a consolidated operating loss of $35.5–$36 million.
Net sales for Q2 were $2.8–$2.82 billion; gross margin was $214.7 million (8% of sales).
Phosphate: $1.25–$1.246 billion net sales, $104 million operating loss, $128 million adjusted EBITDA.
Potash: $650 million net sales, $195 million operating earnings, $278 million adjusted EBITDA.
Mosaic Fertilizantes: $1.03–$1.034 billion net sales, $41 million operating loss, $60 million adjusted EBITDA.
Outlook and guidance
Q3 2026 phosphate sales volumes expected at 1.1–1.4 million tonnes, DAP prices $820–$840/tonne.
Q3 2026 potash sales volumes expected at 2.0–2.2 million tonnes, MOP prices $270–$290/tonne.
2026 capital expenditures guidance reduced to $1.2 billion; SG&A for the year expected at $510–$530 million.
Potash production for 2026 expected at 9 million tonnes, with volumes weighted to the second half.
Management expects liquidity and credit facilities to be sufficient for operational and capital needs over the next 12 months.
Latest events from The Mosaic Company
- Q1 2026 loss driven by asset charges, raw material volatility, and production curtailments.MOS
Q1 20265 Aug 2026 - 55% EBITDA growth by 2030 is targeted through efficiency, digital, and biosciences initiatives.MOS
Investor Day 20258 Jul 2026 - Q3 2025 net income and EBITDA surged on strong Brazil, phosphate, and potash results.MOS
Q3 20258 Jul 2026 - Q4 net income $169M, strong cost actions, and asset sales set up a positive 2025 outlook.MOS
Q4 20248 Jul 2026 - Shareholders will vote on directors, auditor ratification, and executive pay, with strong ESG focus.MOS
Proxy filing16 Apr 2026 - 2025 net income was $541M; asset sales and cost savings set up stronger 2026 cash flow.MOS
Q4 202515 Apr 2026 - Q2 2024 net loss driven by FX and price headwinds, but cost savings and capital returns advanced.MOS
Q2 20242 Feb 2026 - Q3 net income reached $122M on strong phosphate margins and robust capital returns.MOS
Q3 202414 Jan 2026 - Board independence, pay-for-performance, and ESG integration drive governance and strategy.MOS
Proxy Filing1 Dec 2025